STAT3

You have access
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
KEITA GOTO, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, HIROTAKA FUCHIZAWA, YUKI NAKAMURA, YUTA SANO, SHOTARO MATSUOKA, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA

Anticancer Research May 2026, 46 (5) 2445-2453; DOI: https://doi.org/10.21873/anticanres.18129
You have access
Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer
MAI LY THI NGUYEN, LAN ANH BUI, CHI PHAM, PHUONG LINH THI NHAM, VAN MAO CAN, TRAN DUY HAI DOAN, PRZEMYSLAW BOZKO, KHAC CUONG BUI and LINH TOAN NGUYEN

Anticancer Research July 2025, 45 (7) 3059-3068; DOI: https://doi.org/10.21873/anticanres.17670
You have access
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer
HIROTAKA FUCHIZAWA, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, MASAHARU INOUE, KOUKI MITANI, YUTA SANO, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA

Anticancer Research May 2024, 44 (5) 1925-1930; DOI: https://doi.org/10.21873/anticanres.16994
Open Access
Brain Metastases Are Regulated by Immuno-inflammatory Signaling Pathways Governed by STAT3, MAPK and Tumor Suppressor p53 Status: Possible Therapeutic Targets
SABRINA L. ZELLER, ERIS SPIROLLARI, ALIS J. DICPINIGAITIS, JOHN V. WAINWRIGHT, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL

Anticancer Research January 2024, 44 (1) 13-22; DOI: https://doi.org/10.21873/anticanres.16783
You have access
Association of STAT3, CYP3A5, and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients
MASAAKI TANDA, KAZUHIRO YAMAMOTO, TOMOKI HORI, HIROKI NISHIGUCHI, MIKI YAGI, MICHIKO SHIMIZU, TORU KONISHI, TOMONORI OZAKI, NATSUE YOSHIOKA, MOTOKO TACHIHARA, TAKEFUMI ITO, SHIGEKI IKUSHIMA, TOMOHIRO OMURA and IKUKO YANO

Anticancer Research April 2023, 43 (4) 1775-1783; DOI: https://doi.org/10.21873/anticanres.16331
You have access
Isophysalin A Inhibits the Stemness of Breast Cancer Cells Possibly via Stat3 and IL-6 Signaling
YU-CHAN KO, HACK SUN CHOI, SU-LIM KIM and DONG-SUN LEE

Anticancer Research March 2023, 43 (3) 1091-1101; DOI: https://doi.org/10.21873/anticanres.16254
You have access
Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells
WEI-TING CHEN, YUAN-HSIN TSAI, PEGGY TAN, FEI-TING HSU, HUI-MIN DAVID WANG, WEI-CHIN LIN, FENG-HUEI LIN and CHING-TE WU

Anticancer Research March 2023, 43 (3) 1193-1199; DOI: https://doi.org/10.21873/anticanres.16265
You have access
Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway
CHUNG-YI LIU, TZU-HSUAN CHANG, CHIN-HSUAN HSIEH, YING-HSU CHANG, JACOB SEE-TONG PANG and CHENG-KENG CHUANG

Anticancer Research October 2022, 42 (10) 4753-4762; DOI: https://doi.org/10.21873/anticanres.15980
You have access
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo
PEN-AN LIAO, PEI-YI CHU, ZHAO-LIN TAN, FEI-TING HSU, YANG-CHENG LEE and HSING-JU WU

Anticancer Research August 2022, 42 (8) 3807-3814; DOI: https://doi.org/10.21873/anticanres.15871
You have access
Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells
YANG-CHENG LEE, YUEH-SHAN WENG, HSIAO-YU WANG, FEI-TING HSU, FU-SHIN CHUEH, JENG-YUAN WU, WEI-LUNG CHEN and JIANN-HWA CHEN

Anticancer Research August 2022, 42 (8) 3825-3833; DOI: https://doi.org/10.21873/anticanres.15873

Main menu

User menu

Search

STAT3

Pages